Skip to main content
Clinical Trials/NL-OMON43561
NL-OMON43561
Completed
Phase 3

Pre-emptive, OCT guided angioplasty of vulnerable, intermediate coronary lesions: a randomized trial - the PECTUS trial

Vrije Universiteit Medisch Centrum0 sites1,000 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Atherosclerosis
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
1000
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- patients with acute myocardial infarction and residual, non\-obstructive CAD, with the possibility of plaque vulnerability.
  • \- the coronary lesion must be suitable for PCI with a commercially available BVS.

Exclusion Criteria

  • \- Refusal or inability to provide informed consent.
  • \- \< 18 years of age
  • \- Previous CABG.
  • \- Indication for revascularization by CABG.
  • \- Target vessel diameter \< 2,5 mm or \>4\.0 mm
  • \- Anatomy or lesions unsuitable for OCT catheter crossing or imaging (aorta\-ostial lesions, small diameter segment, severe calcifications)
  • \- Anatomy unsuitable for BVS placement (left main, bifurcation stenting, sidebranch (\> 2 mm) involvement).
  • \- Target lesion is instent restenosis
  • \- Target lesion is chronic total occlusion
  • \- Severe kidney disease defined as an eGFR \< 30 ml/min.

Outcomes

Primary Outcomes

Not specified

Similar Trials